Frédéric Rieux-Laucat

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Steven M. Holland, Amelia Licari, Gian Luigi Marseglia, 2020, Science.

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

Bodo Grimbacher, James Curtis, Siobhan O. Burns, 2017, The Journal of allergy and clinical immunology.

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Nicolas Carlier, Aurélien Corneau, Nicolas Roche, 2020, Science.

Efficacy of gene therapy for X-linked severe combined immunodeficiency.

Frederic D. Bushman, Lily E. Leiva, Capucine Picard, 2010, The New England journal of medicine.